According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
HYH has been the topic of a number of other reports. Stifel Nicolaus boosted their price objective on shares of Halyard Health from $32.00 to $37.00 and gave the company a buy rating in a research report on Tuesday, June 14th. TheStreet raised shares of Halyard Health from a sell rating to a hold rating in a research report on Friday, July 8th. Finally, Deutsche Bank AG boosted their price objective on shares of Halyard Health from $36.00 to $41.00 and gave the company a buy rating in a research report on Wednesday, August 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company. Halyard Health has an average rating of Hold and an average price target of $34.20.
Halyard Health (NYSE:HYH) opened at 34.31 on Wednesday. The firm’s market capitalization is $1.60 billion. The firm’s 50-day moving average is $35.25 and its 200 day moving average is $32.65. Halyard Health has a one year low of $22.76 and a one year high of $37.31.
Halyard Health (NYSE:HYH) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.45 EPS for the quarter, beating the Zacks’ consensus estimate of $0.36 by $0.09. Halyard Health had a negative net margin of 27.63% and a positive return on equity of 8.91%. The firm had revenue of $400 million for the quarter, compared to the consensus estimate of $383.08 million. During the same period in the previous year, the firm posted $0.52 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. Analysts forecast that Halyard Health will post $1.82 EPS for the current fiscal year.
Several hedge funds have recently modified their holdings of the company. IFP Advisors Inc boosted its stake in shares of Halyard Health by 1.9% in the second quarter. IFP Advisors Inc now owns 3,141 shares of the company’s stock worth $102,000 after buying an additional 58 shares during the last quarter. Tower Research Capital LLC TRC purchased a new stake in shares of Halyard Health during the second quarter worth $104,000. LS Investment Advisors LLC boosted its stake in shares of Halyard Health by 25.6% in the second quarter. LS Investment Advisors LLC now owns 3,241 shares of the company’s stock worth $105,000 after buying an additional 661 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of Halyard Health during the second quarter worth $109,000. Finally, Point72 Asset Management L.P. purchased a new stake in shares of Halyard Health during the second quarter worth $182,000. Institutional investors and hedge funds own 82.93% of the company’s stock.
About Halyard Health
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.